COVID-19: Bharat Biotech receives DCGI approval for India’s first intranasal vaccine



The Drugs Controller General of India (DCGI) granted Bharat Biotech emergency use authorization for the Intranasal Covid-19 vaccine on September 6. This will be India’s first nasal vaccine for COVID-19.

Mansukh Mandaviya, Union Minister of Health and Family Welfare, described it as a “significant boost” to India’s fight against Covid-19.

He took to Twitter and said, “Big Boost to India’s Fight Against COVID-19! Bharat Biotech’s ChAd36-SARS-CoV-S COVID-19 (Chimpanzee Adenovirus Vectored) recombinant nasal vaccine approved by @CDSCO_INDIA_INF for primary immunization against COVID-19 in 18+ age group for restricted use in emergency situation.”

“This step will further strengthen our collective fight against the pandemic. India has harnessed its science, R&D, and human resources in the fight against COVID-19 under PM @NarendraModi Ji’s leadership,” he added.

He also said that we will defeat Covid-19 with a science-driven approach.

“With the science-driven approach and Sabka Prayas, we will defeat COVID-19,” he said.

Avatar photo

Dr. Kirti Sisodhia

Content Writer

CATEGORIES Business Agriculture Technology Environment Health Education

info@seepositive.in
Rishita Diwan – Chief editor

8839164150
Rishika Choudhury – Editor

8327416378

email – hello@seepositive.in
Office

Address: D 133, near Ram Janki Temple, Sector 5, Jagriti Nagar, Devendra Nagar, Raipur, Chhattisgarh 492001

FOLLOW US

GET OUR POSITIVE STORIES

Uplifting stories, positive impact and updates delivered straight into your inbox.

You have been successfully Subscribed! Ops! Something went wrong, please try again.
CATEGORIES Business Agriculture Technology Environment Health Education

SHARE YOUR STORY

info@seepositive.in

SEND FEEDBACK

contact@seepositive.in

FOLLOW US

GET OUR POSITIVE STORIES

Uplifting stories, positive impact and updates delivered straight into your inbox.

You have been successfully Subscribed! Ops! Something went wrong, please try again.